Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.